Hyperuricemia, cardiovascular disease, and the metabolic syndrome

Journal of Rheumatology

Volumn 36, Issue 12, 2009, Pages 2842-2843

  Indraratna, Praveen L ^a   Williams, Kenneth M ^a   Graham, Garry G ^a   Day, Richard O ^a  

^a UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN II; ANGIOTENSINOGEN; CREATININE; RENIN; URIC ACID;

ADIPOSE TISSUE; ATHEROSCLEROSIS; BLOOD PRESSURE; CARDIOVASCULAR DISEASE; CREATININE CLEARANCE; DISEASE ASSOCIATION; HUMAN; HYPERTENSION; HYPERURICEMIA; KIDNEY FUNCTION; KIDNEY PROXIMAL TUBULE; LETTER; METABOLIC SYNDROME X; OBESITY; PATHOGENESIS; PREECLAMPSIA; PRIORITY JOURNAL; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; RISK FACTOR; SODIUM TRANSPORT; URIC ACID BLOOD LEVEL;

ANGIOTENSIN II; CARDIOVASCULAR DISEASES; HUMANS; HYPERTENSION; HYPERURICEMIA; METABOLIC SYNDROME X; OBESITY; RENIN-ANGIOTENSIN SYSTEM; RISK FACTORS; URIC ACID;

EID: 72449208160     PISSN: 0315162X     EISSN: None     Source Type: Journal    
DOI: 10.3899/jrheum.090500     Document Type: Letter

References (10)

1. Neogi T. Asymptomatic hyperuricemia: Perhaps not so benign? [editorial]. J Rheumatol 2008;35:734-737 (Pubitemid 351747108)
2. Marasini B, Massarotti M. What rheumatologists should know about gout and cardiovascular disease [letter]. J Rheumatol 2009;36:854-855
3. Puig J, Martinez M. Hyperuricemia, gout and the metabolic syndrome. Curr Opin Rheumatol 2008;20:187-191
4. Strasak A, Kelleher C, Brant L, Rapp K, Ruttmann E, Concin H, et al. Serum uric acid is an independent predictor for all major forms of cardiovascular death in 28,613 elderly women: A prospective 21-year follow-up study. Int J Cardiol 2008;125:232-239
5. Sarzani R, Salvi F, Dessì-Fulgheri P, Rappelli A. Renin-angiotensin system, natriuretic peptides, obesity, metabolic syndrome, and hypertension: an integrated view in humans. J Hypertens 2008;26:831-843 (Pubitemid 351540757)
6. Galletti F, Strazzullo P. Involvement of the renin-angiotensin system in obesity: Older and newer pathways. Nutr Metab Cardiovasc Dis 2007;17:699-704. (Pubitemid 350088442)
7. Ferris T, Gorden P. Effect of angiotensin and norepinephrine upon urate clearance in man. Am J Med 1968;44:359-365
8. Emmerson B, Ravenscroft P, Williams G. The effect of urine flow rate on urate clearance. Adv Exp Med Biol 1977;76B:23-29
9. Shah D. The role of RAS in the pathogenesis of preeclampsia. Curr Hypertens Rep 2006;8:144-152
10. Enomoto A, Kimura H, Chairoungdua A, Shigeta Y, Jutabha P, Cha S, et al. Molecular identification of a renal urate-anion exchanger that regulates blood urate levels. Nature 2002;417:447-452 (Pubitemid 34563537)